John Allan MD (Saint Louis University)

Dr. John Allan, MD, is a distinguished hematologist-oncologist at Weill Cornell Medical College, NY, NY, United States, where his clinical and research expertise focuses on hematologic malignancies. He received his medical education from Saint Louis University and has been recognized for his scholarly excellence through membership in Alpha Omega Alpha, the Arnold P. Gold Humanism in Medicine Honor Society, and Alpha Sigma Nu Jesuit Honor Society. Dr. Allan is an active member of the American Society of Clinical Oncology and the American Society of Hematology, reflecting his commitment to advancing cancer care. His research contributions include over 77 indexed publications, most notably his 2020 multicenter international study on outcomes of COVID-19 in patients with chronic lymphocytic leukemia, which has been cited 278 times and has significantly informed clinical management during the pandemic.